EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Quzhuo tongbi formula for reducing gout flare related to uric acid lowering treatment: Study protocol for a multiple-center, randomized, double-blind, placebo, parallel-controlled clinical trial

Hejing Pan, Xuanlin Li, Shan Wu, Donghai Zhou, Haojie Guan, Haoyu Wu, Qiao Wang, Yujun Tang, Xuanming Hu, Meijiao Wang, Mingqian Zhou, Runyue Huang und 4 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0327864 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Hejing Pan und 15 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Gout, Uric Acid, Drugs, Chinese Herbal, Gout Suppressants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gout, a prevalent metabolic rheumatic disease, arises from the accumulation of monosodium urate (MSU) crystals in joints, directly associated with hyperuricemia. Long-term or lifelong urate-lowering therapy (ULT) stands as the primary management strategy. However, there is a significant risk of gout flares during ULT, and current methods have drawbacks, including side effects. Previous research has suggested a potential benefit of the Qu-zhuo Tong-bi formula (QTF) in the treatment and prevention of gout. This study aims to evaluate the effectiveness and safety of QTF in reducing gout flares during ULT.

Method

This is a multi-center, randomized, double-blind, placebo, parallel-controlled clinical trial conducted in four hospitals in Zhejiang Province, China. A total of 144 patients, aged 18–80 years, will be randomly allocated to either the intervention group (QTF + febuxostat) or the control group (placebo + febuxostat) for a 12-week treatment period. The primary outcome measure is the frequency of gout flares. Secondary outcome measures include the time from the patient’s enrollment to the first occurrence of gout flare (in days), duration of gout flare (in days), health assessment questionnaire disability index (HAQ-DI), pain level (visual analog scale – VAS), rate of achieving target uric acid levels. Occurrences of adverse events, and results from electrocardiograms and laboratory tests, will be monitored.

Discussion

The findings from this study will offer valuable evidence supporting the efficacy of the QTF in reducing gout flares during ULT.

Trial registration

ChiCTR20084417 Register on May 16, 2024.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoutUric AcidDrugs, Chinese HerbalGout SuppressantsHumansDouble-Blind MethodMiddle AgedAdultMaleAgedFemaleAdolescentYoung AdultAged, 80 and overFebuxostatHyperuricemiaChinaRandomized Controlled Trials as TopicMulticenter Studies as Topic

Substanzen

Uric AcidDrugs, Chinese HerbalGout SuppressantsFebuxostat

Autor:innen und Institutionen

  • College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
  • the First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • the Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Shengzhou People's Hospital, Shengzhou, China.
  • Huzhou Hospital of Traditional Chinese Medicine, Huzhou, China.
  • the Second Affiliated Hospital of Guangzhou University of Chinese Medicine.

ORCID-Profile: Lin Huang

Zitieren

APA

Pan, H., Li, X., Wu, S., Zhou, D., Guan, H., Wu, H., Wang, Q., Tang, Y., Hu, X., Wang, M., Zhou, M., Huang, R., Liu, L., Chen, Y., Wen, C., & Huang, L. (2025). Quzhuo tongbi formula for reducing gout flare related to uric acid lowering treatment: Study protocol for a multiple-center, randomized, double-blind, placebo, parallel-controlled clinical trial. PLOS One. https://doi.org/10.1371/journal.pone.0327864

Vancouver

Pan H, Li X, Wu S, Zhou D, Guan H, Wu H, et al. Quzhuo tongbi formula for reducing gout flare related to uric acid lowering treatment: Study protocol for a multiple-center, randomized, double-blind, placebo, parallel-controlled clinical trial. PLOS One. 2025. doi:10.1371/journal.pone.0327864

BibTeX
@article{Pan2025,
  author = {Pan, Hejing and Li, Xuanlin and Wu, Shan and Zhou, Donghai and Guan, Haojie and Wu, Haoyu and Wang, Qiao and Tang, Yujun and Hu, Xuanming and Wang, Meijiao and Zhou, Mingqian and Huang, Runyue and Liu, Lei and Chen, Yaolong and Wen, Chengping and Huang, Lin},
  title = {Quzhuo tongbi formula for reducing gout flare related to uric acid lowering treatment: Study protocol for a multiple-center, randomized, double-blind, placebo, parallel-controlled clinical trial},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0327864}
}
Kostenlos starten →